The purpose of this legislation, known as the "Lower Drug Costs for Families Act," is to reduce prescription drug costs for consumers by applying inflation rebates to drugs sold in the commercial market. This aims to ensure that the prices of prescription drugs do not increase faster than inflation, making medications more affordable for families. Key provisions of the legislation include the application of prescription drug inflation rebates to both Part B and Part D drugs in the commercial market.